Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer

  Free Subscription


11.11.2024

1 Aging Med (Milton)
1 Biochem Biophys Res Commun
1 Biotechnol Appl Biochem
2 BMC Cancer
1 BMC Infect Dis
1 BMC Womens Health
1 Bratisl Lek Listy
2 Cancer Cytopathol
1 Cancer Prev Res (Phila)
1 Cancer Radiother
1 Cancer Rep (Hoboken)
1 Cell Signal
1 Cleve Clin J Med
3 Cureus
1 DNA Cell Biol
1 FEBS Open Bio
1 Front Cell Infect Microbiol
1 Front Oncol
1 Front Pharmacol
1 Front Public Health
1 Gene
1 Int J Cancer
2 Int J Gynecol Cancer
1 Int J Health Sci (Qassim)
2 J Cancer Educ
1 J Gynecol Oncol
1 J Int Med Res
1 J Mater Chem B
1 J Pathol Inform
1 J Womens Health (Larchmt)
1 JNCI Cancer Spectr
2 Lancet Public Health
1 Lancet Reg Health Am
1 Med Dosim
1 Mol Biomed
1 Nucl Med Commun
1 Oncol Ther
1 Prev Med
2 Public Health Nurs
1 Radiat Oncol
1 Res Health Serv Reg
1 Sci Rep
1 SLAS Technol
1 Stem Cell Res Ther
1 Transl Oncol
1 Tumour Virus Res
1 Vopr Kurortol Fizioter Lech Fiz Kult


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aging Med (Milton)

  1. REZAEI F, Mazidimoradi A, Pasokh Z, Mobasheri F, et al
    Global trend of cervical cancer among women aged 55 and older from 2010 to 2019: An analysis by socio-demographic index and geographic regions.
    Aging Med (Milton). 2024;7:614-635.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  2. RAJAWAT J, Banerjee M
    Poly(ADP-ribose) polymerase1 (PARP1) and PARP inhibitors: New frontiers in cervical cancer.
    Biochem Biophys Res Commun. 2024;738:150943.
    PubMed         Abstract available


    Biotechnol Appl Biochem

  3. PANDEY P, Ramniwas S, Pandey S, Lakhanpal S, et al
    Elucidating the anticancerous efficacy of genistein via modulating HPV (E7 and E6) oncogenes expression and apoptotic induction in cervical cancer cells.
    Biotechnol Appl Biochem. 2024 Nov 3. doi: 10.1002/bab.2691.
    PubMed         Abstract available


    BMC Cancer

  4. TAO H, Yu F, Yang L, Pei X, et al
    Comparing the performance of DeoxyriboNucleic Acid methylation analysis and cytology for detecting cervical (pre)cancer in women with high-risk human papillomavirus-positive status in a gynecologic outpatient population.
    BMC Cancer. 2024;24:1352.
    PubMed         Abstract available

  5. DEDEY F, Nsaful J, Nartey E, Labi J, et al
    Assessing the impact of cervical cancer education in two high schools in Ghana.
    BMC Cancer. 2024;24:1359.
    PubMed         Abstract available


    BMC Infect Dis

  6. PERERA K, Mapitigama KN, Abeysena H
    Prevalence of vaginal and cervical HPV infection among 35-year age cohort ever-married women in Kalutara district of Sri Lanka and the validity of vaginal HPV/DNA specimen as a cervical cancer screening tool: a cross-sectional study.
    BMC Infect Dis. 2024;24:1249.
    PubMed         Abstract available


    BMC Womens Health

  7. CHEN X, Li J, Zeng Q, Huang W, et al
    Construction of a nomogram for personalized prediction of lower limb lymphedema risk after cervical cancer surgery.
    BMC Womens Health. 2024;24:593.
    PubMed         Abstract available


    Bratisl Lek Listy

  8. NAKOV I
    Quality of food intake and spontaneous clearance of Human papillomavirus in women.
    Bratisl Lek Listy. 2024;125:719-723.
    PubMed         Abstract available


    Cancer Cytopathol

  9. ZENG X, Starr D, Li J, Bi X, et al
    AICyte-alone capabilities as an independent screener for triaging cervical cytology using a 50% negative cutoff value.
    Cancer Cytopathol. 2024;132:723-730.
    PubMed         Abstract available

  10. FENG FX, Birdsong GG, Wei J, Dababneh MN, et al
    Retrospective analysis of HPV infection: Cotesting and HPV genotyping in cervical cancer screening within a large academic health care system.
    Cancer Cytopathol. 2024 Nov 5. doi: 10.1002/cncy.22916.
    PubMed         Abstract available


    Cancer Prev Res (Phila)

  11. OTORKPA OJ, Onifade AA, Otorkpa CO
    The Surge in Human Papillomavirus Vaccine Rejection in Nigeria.
    Cancer Prev Res (Phila). 2024;17:497-498.
    PubMed         Abstract available


    Cancer Radiother

  12. CAMPRODON G, Gabro A, El Ayachi Z, Chopra S, et al
    Personalized strategies for brachytherapy of cervix cancer.
    Cancer Radiother. 2024;28.
    PubMed         Abstract available


    Cancer Rep (Hoboken)

  13. ZHANG X, Yu H, Chen K, Ding B, et al
    Definite Treatment Delay With Neoadjuvant Chemotherapy and Longitudinal Monitoring by Circulating Tumor DNA for Advanced Cervical Cancer During Pregnancy: A Case Series and Literature Review.
    Cancer Rep (Hoboken). 2024;7:e70021.
    PubMed         Abstract available


    Cell Signal

  14. LUO X, Jian M, Wu P, Wu Y, et al
    STIM1 promotes cervical cancer progression through autophagy activation via TFEB nuclear translocation.
    Cell Signal. 2024;125:111500.
    PubMed         Abstract available


    Cleve Clin J Med

  15. GOLD RS, Williams M, Wainstein HM
    Cervical cancer screening in high-risk patients: Clinical challenges in primary care.
    Cleve Clin J Med. 2024;91:693-703.
    PubMed         Abstract available


    Cureus

  16. GHAFOURI M, Miller S, Burmeister J, Boggula R, et al
    Adaptive Approach to Treating Cervical Cancer in a Patient With Dramatic Uterine Movement.
    Cureus. 2024;16:e72938.
    PubMed         Abstract available

  17. PETRE I, Negru S, Dragomir R, Bordianu A, et al
    Artificial Intelligence Algorithms in Predictive Factors for Hematologic Toxicities During Concurrent Chemoradiation for Cervical Cancer.
    Cureus. 2024;16:e70665.
    PubMed         Abstract available

  18. ADEBISI AA, Onobun DE, Orji C, Ononye R, et al
    Barriers to the Completion of Radiation Therapy in Cervical Cancer Treatment in Nigeria: A Review of Socioeconomic, Geographical, and Psychosocial Factors.
    Cureus. 2024;16:e70747.
    PubMed         Abstract available


    DNA Cell Biol

  19. HUANG C, Xue L, Lin X, Shen Y, et al
    Histone Lactylation-Driven GPD2 Mediates M2 Macrophage Polarization to Promote Malignant Transformation of Cervical Cancer Progression.
    DNA Cell Biol. 2024 Nov 6. doi: 10.1089/dna.2024.0122.
    PubMed         Abstract available


    FEBS Open Bio

  20. TSUNEMATSU R, Mariya T, Umemoto M, Ogawa S, et al
    Microbiological investigation of pregnancies following vaginal radical trachelectomy using 16S rRNA sequencing of FFPE placental specimens.
    FEBS Open Bio. 2024;14:1825-1836.
    PubMed         Abstract available


    Front Cell Infect Microbiol

  21. WANG Y, Chen F, Qu W, Gong Y, et al
    Alternative splicing in the genome of HPV and its regulation.
    Front Cell Infect Microbiol. 2024;14:1443868.
    PubMed         Abstract available


    Front Oncol

  22. YOSEF T, Birhanu B, Shifera N, Bekele BB, et al
    Determinants of cervical cancer screening uptake among reproductive-age women in southwest Ethiopia: a case-control study.
    Front Oncol. 2024;14:1424810.
    PubMed         Abstract available


    Front Pharmacol

  23. CAI H, Fang L, Lin J, Zheng Z, et al
    Atezolizumab plus bevacizumab and chemotherapy versus bevacizumab plus chemotherapy for metastatic cervical cancer: a cost-effectiveness analysis.
    Front Pharmacol. 2024;15:1476256.
    PubMed         Abstract available


    Front Public Health

  24. FALLATAH DI, Khalil MA, Abd ElHafeez S, Gouda S, et al
    Factors influencing human papillomavirus vaccine uptake among parents and teachers of schoolgirls in Saudi Arabia: a cross-sectional study.
    Front Public Health. 2024;12:1403634.
    PubMed         Abstract available


    Gene

  25. CORTES-HERNANDEZ U, Lizardi-Aguilera TM, Noriega-Mejia BJ, Gonzalez-Macias J, et al
    Prostaglandin E(2) suppresses KCNH1 gene expression and inhibits the proliferation of CaSki cervical cells through its four prostanoid PTGER subtypes.
    Gene. 2025;933:148997.
    PubMed         Abstract available


    Int J Cancer

  26. LOUVANTO K, Verhoef L, Pimenoff V, Eriksson T, et al
    Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions.
    Int J Cancer. 2024;155:1549-1557.
    PubMed         Abstract available


    Int J Gynecol Cancer

  27. CHEN M, Han L, Wang Y, Chen Y, et al
    Association between Silva pattern-based classification and endocervical adenocarcinoma: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2024;34:1704-1710.
    PubMed         Abstract available

  28. MEKURIA SF, Biazin H, Abebe T, Borgfeldt C, et al
    Comparing visual inspection with acetic acid, with and without Lugol's Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trial.
    Int J Gynecol Cancer. 2024;34:1691-1697.
    PubMed         Abstract available


    Int J Health Sci (Qassim)

  29. RASHEED Z
    MicroRNA-183-5p negatively regulates interleukin-8 expression in cervical cancer cells.
    Int J Health Sci (Qassim). 2024;18:25-30.
    PubMed         Abstract available


    J Cancer Educ

  30. SOLIMAN AS
    The Changing Landscape of Cervical Cancer in Africa: Opportunities for Patient, Public, and Professional Education.
    J Cancer Educ. 2024 Nov 5. doi: 10.1007/s13187-024-02528.
    PubMed        

  31. SMITH PJ, Wallington SF
    Disparities in Cervical Cancer Knowledge and Trust in Information Sources Among Diverse American Women.
    J Cancer Educ. 2024 Nov 6. doi: 10.1007/s13187-024-02534.
    PubMed         Abstract available


    J Gynecol Oncol

  32. TERMRUNGRUANGLERT W, Khemapech N, Vasuratna A, Havanond P, et al
    Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting.
    J Gynecol Oncol. 2024;35:e85.
    PubMed         Abstract available


    J Int Med Res

  33. USHIO E, Mizushima T, Sukegawa A, Saigusa Y, et al
    Risk factors for positive cervical cytology during early pregnancy screening and awareness of positive cytological results in Japan: a report from the Pregnant Women Health Initiative.
    J Int Med Res. 2024;52:3000605241285548.
    PubMed         Abstract available


    J Mater Chem B

  34. ZHANG J, Liu Y, Guan Y, Zhang Y, et al
    A single-injection vaccine providing protection against two HPV types.
    J Mater Chem B. 2024;12:11237-11250.
    PubMed         Abstract available


    J Pathol Inform

  35. SHAKIL R, Islam S, Akter B
    A precise machine learning model: Detecting cervical cancer using feature selection and explainable AI.
    J Pathol Inform. 2024;15:100398.
    PubMed         Abstract available


    J Womens Health (Larchmt)

  36. ADEGBOYEGA A, Kang J, Aroh A, Williams LB, et al
    Perceived Barriers to Pap Screening Influence Adherence to Screening Recommendations Among Black Women.
    J Womens Health (Larchmt). 2024;33:1482-1491.
    PubMed         Abstract available


    JNCI Cancer Spectr

  37. ANDO H, Katoh Y, Kobayashi O, Ikeda Y, et al
    Low CD86 expression is a predictive biomarker for clinical response to the therapeutic human papillomavirus vaccine IGMKK16E7: results of a post hoc analysis.
    JNCI Cancer Spectr. 2024;8:pkae091.
    PubMed         Abstract available


    Lancet Public Health

  38. WANG J, Elfstrom KM, Dillner J
    Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden.
    Lancet Public Health. 2024;9:e886-e895.
    PubMed         Abstract available

  39. ALMONTE M, Hernandez ML, Adsul P
    Implementation efforts to support transition to HPV-based cervical cancer screening.
    Lancet Public Health. 2024;9:e838-e839.
    PubMed        


    Lancet Reg Health Am

  40. TATAR O, Haward B, Perez S, Zhu P, et al
    On the path toward cervical cancer elimination in Canada: a national survey of factors influencing women's intentions to participate in human papillomavirus test-based primary cervical screening.
    Lancet Reg Health Am. 2024;39:100901.
    PubMed         Abstract available


    Med Dosim

  41. GRAY T, Cherian S, Amarnath S, Guo B, et al
    Method to assess the need for re-planning HDR brachytherapy tandem and ring treatments.
    Med Dosim. 2024;49:298-306.
    PubMed         Abstract available


    Mol Biomed

  42. ZHAO X, Liu Z, Qin H, Liu Y, et al
    T cell receptor repertoire characteristics and therapeutic potential of tumor infiltrating lymphocytes (TILs) derived from metastatic lymph node in cervical cancer.
    Mol Biomed. 2024;5:51.
    PubMed        


    Nucl Med Commun

  43. LI J, Cui N, Wang Y, Li W, et al
    Prediction of preoperative lymph-vascular space invasion and survival outcomes of cervical squamous cell carcinoma by utilizing 18F-FDG PET/CT imaging at early stage.
    Nucl Med Commun. 2024 Oct 2. doi: 10.1097/MNM.0000000000001909.
    PubMed         Abstract available


    Oncol Ther

  44. MONK BJ, van Mens S, Hale O, Boer J, et al
    Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United States.
    Oncol Ther. 2024 Nov 5. doi: 10.1007/s40487-024-00311.
    PubMed         Abstract available


    Prev Med

  45. BRENNAN KJ, Reay JL
    Emotional barriers pose the greatest threat to cervical cancer screening for young adult women in the United Kingdom.
    Prev Med. 2024;189:108160.
    PubMed         Abstract available


    Public Health Nurs

  46. GURDAL Y, Ilhan N
    Health beliefs and associated factors related to HPV and HPV vaccination in a sample of Turkish women: A cross-sectional study.
    Public Health Nurs. 2024;41:1342-1352.
    PubMed         Abstract available

  47. KUCUKKAYA B, Cangol Sogut S, Cangol E
    The relationship between HPV testing attitudes and beliefs, knowledge, and vaccination attitudes: A cross-sectional study.
    Public Health Nurs. 2024;41:1466-1479.
    PubMed         Abstract available


    Radiat Oncol

  48. LU Z, Zhu G, Qiu Z, Guo H, et al
    3D-printed brachytherapy in patients with cervical cancer: improving efficacy and safety outcomes.
    Radiat Oncol. 2024;19:152.
    PubMed         Abstract available


    Res Health Serv Reg

  49. KHAN MJ, Kannan P, Sayma, Winser SJ, et al
    Population-based cross-sectional survey of cervical cancer screening prevalence and socio-demographic correlates in Bangladeshi women.
    Res Health Serv Reg. 2024;3:17.
    PubMed         Abstract available


    Sci Rep

  50. PENG H, Liu T, Li P, Yang F, et al
    Automatic delineation of cervical cancer target volumes in small samples based on multi-decoder and semi-supervised learning and clinical application.
    Sci Rep. 2024;14:26937.
    PubMed         Abstract available


    SLAS Technol

  51. PING Q, Chen Q, Li N
    Identification of m(6)A-related lncRNAs prognostic signature for predicting immunotherapy response in cervical cancer.
    SLAS Technol. 2024 Oct 26:100210. doi: 10.1016/j.slast.2024.100210.
    PubMed         Abstract available


    Stem Cell Res Ther

  52. YE M, Liu T, Miao L, Ji H, et al
    Cisplatin-encapsulated TRAIL-engineered exosomes from human chorion-derived MSCs for targeted cervical cancer therapy.
    Stem Cell Res Ther. 2024;15:396.
    PubMed         Abstract available


    Transl Oncol

  53. YANG X, Gao X, Xu C, Ni T, et al
    Cryoablation synergizes with anti-PD-1 immunotherapy induces an effective abscopal effect in murine model of cervical cancer.
    Transl Oncol. 2024;51:102175.
    PubMed         Abstract available


    Tumour Virus Res

  54. BROOKE G, Wendel S, Banerjee A, Wallace N, et al
    Opportunities to Advance Cervical Cancer Prevention and Care.
    Tumour Virus Res. 2024 Oct 25:200292. doi: 10.1016/j.tvr.2024.200292.
    PubMed         Abstract available


    Vopr Kurortol Fizioter Lech Fiz Kult

  55. BLINOV DV, Solopova AG, Gameeva EV, Badalov NG, et al
    [Impact of various rehabilitation programs on anxiety and depression after surgery of early-stage cervical cancer].
    Vopr Kurortol Fizioter Lech Fiz Kult. 2024;101:40-44.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.